Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Blue Razz: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)
Recalled by Extract Labs, INC. on Aug 26, 2025
Reason for Recall
Potential peanut protein cross-contact.
Product Description
Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Blue Razz: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)
Distribution
Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand.
What Should You Do?
- 1.Check your kitchen for this product immediately.
- 2.Do not consume the recalled product.
- 3.Return the product to where you bought it for a full refund, or throw it away.
- 4.If you have experienced any health issues, contact your healthcare provider.
Browse Related Recalls
Terms Explained
- Class II Recall — learn what this means in food safety
- FDA Food Recall — learn what this means in food safety
The this entity record above pulls directly from the FDA openFDA enforcement-report API. What follows is the per-entity context — how this entity sits in the broader U.S. FDA food, drug, and device recalls distribution and which underlying factors drive the headline numbers.
Every number on this page links back to the FDA openFDA enforcement-report API; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. consumer-product recalls. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.
Source: FDA Recalls, Market Withdrawals and Safety Alerts, 2026.